ACTO's CXZone Achieves Dual Honors in 2025 Pharmaceutical Technology Excellence Awards
In an impressive display of innovation, ACTO, a leading provider of AI-first solutions for the life sciences sector, has announced that its groundbreaking product,
CxZone, received dual accolades in the 2025 Pharmaceutical Technology Excellence Awards. These honors underscore the platform's pioneering role as the first AI-simulated roleplay solution exclusively designed for pharmaceutical field professionals.
The award categories in which CxZone excelled include
Innovation (AI Roleplay) and
Product Launches (Field Simulation). Both recognitions serve to emphasize not only the technical capabilities of the solution but also its commitment to enhancing the effectiveness of pharmaceutical field engagements.
The Vision Behind CxZone
Parth Khanna, CEO of ACTO, expressed pride in the awards, stating, "This recognition validates our purpose-built approach to developing CxZone. Our goal has always been to enable field representatives to engage in more human interactions with healthcare providers. This product allows field professionals to rehearse challenging conversations, experiment with various approaches, and ultimately build their confidence."
The importance of
CxZone becomes even more evident considering the statistics from the field: only
28% of healthcare providers (HCPs) believe their interactions with field representatives address their needs effectively. ACTO's innovative approach strives to bridge this gap, ensuring that pharmaceutical strategies are effectively communicated in the field.
Unique Features of CxZone
AI Roleplay
In the
Innovation (AI Roleplay) category, CxZone addresses ongoing issues in pharmaceutical field engagement. The platform's cutting-edge technology transforms strategy into meaningful, regulatory-compliant conversations with healthcare professionals. The integration of the
Veeva Vault PromoMats and
MedComms allows for scenario-building based on the latest approved content, establishing CxZone as a unique player in the industry.
Field Simulation
In the
Field Simulation category, ACTO has set a new standard by providing field teams with the means to enhance their clinical fluency and product messaging. What sets CxZone apart is its capability to not just equip field reps with basic sales skills, but to provide them with detailed scores and feedback on their clinical understanding and messaging strategies. This emphasis on quality interaction helps ensure that field teams can navigate complex clinical discussions adeptly.
Traditional roleplay exercises often lean towards being uncomfortable or awkward, stifling the productivity of training sessions. CxZone counters this trend with a
gamified, on-demand environment, delivering practice opportunities for field professionals to engage in 'real-life' clinical conversations without the pressure of live observation.
User-Friendly Interface
CxZone comes equipped with an intuitive backend user interface, allowing trainers to design scenarios swiftly. They can customize HCP avatars, outline conversations, set evaluation criteria, and deploy simulations within minutes. This ease-of-use is further enhanced with content that auto-syncs with Veeva PromoMats and MedComms, ensuring that users always practice using the most up-to-date and approved materials.
Commitment to Innovation
As the only AI-simulated roleplay solution tailored for life sciences, CxZone equips field representatives and Medical Science Liaisons (MSLs) with a judgment-free space to practice their skills and gain instant feedback. This feedback is carefully aligned with each company's unique sales processes and coaching models, ultimately enhancing the quality of interactions between HCPs and pharma representatives.
About ACTO and the Excellence Awards
The
Pharmaceutical Technology Excellence Awards, powered by GlobalData, aim to acknowledge exceptional businesses driving innovation and change in the pharmaceutical landscape. ACTO positions itself as an intelligent field excellence (IFE) platform that merges human insight with empathetic artificial intelligence, assuring that field professionals are consistently competent, confident, and credible in their client interactions.
For more insights about CxZone and its transformative potential in pharmaceutical engagement, visit
ACTO's website. Stay updated with ACTO's latest developments by following them on LinkedIn.
Conclusion
ACTO’s achievements with CxZone in the 2025 Pharmaceutical Technology Excellence Awards signify a promising future for pharmaceutical training. As healthcare becomes increasingly complex, solutions like CxZone offer valuable resources for field professionals striving to improve their engagement with healthcare providers.